These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8324912)

  • 1. Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers.
    Gordon RD; Ziesak MD; Tunny TJ; Stowasser M; Klemm SA
    Clin Exp Pharmacol Physiol; 1993 May; 20(5):296-8. PubMed ID: 8324912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of primary aldosteronism in 199 patients referred with hypertension.
    Gordon RD; Stowasser M; Tunny TJ; Klemm SA; Rutherford JC
    Clin Exp Pharmacol Physiol; 1994 Apr; 21(4):315-8. PubMed ID: 7923898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
    Schwartz GL; Turner ST
    Clin Chem; 2005 Feb; 51(2):386-94. PubMed ID: 15681560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary hyperaldosteronism: a missed diagnosis in 'essential hypertensives'?
    Brown MA; Cramp HA; Zammit VC; Whitworth JA
    Aust N Z J Med; 1996 Aug; 26(4):533-8. PubMed ID: 8873937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of primary aldosteronism in the Tayside hypertension clinic population.
    Lim PO; Dow E; Brennan G; Jung RT; MacDonald TM
    J Hum Hypertens; 2000 May; 14(5):311-5. PubMed ID: 10822317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
    Loh KC; Koay ES; Khaw MC; Emmanuel SC; Young WF
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2854-9. PubMed ID: 10946893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing.
    Hood S; Cannon J; Foo R; Brown M
    Clin Med (Lond); 2005; 5(1):55-60. PubMed ID: 15745200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
    Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.
    Ferrari P; Shaw SG; Nicod J; Saner E; Nussberger J
    J Hypertens; 2004 Feb; 22(2):377-81. PubMed ID: 15076197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study.
    Lim PO; Jung RT; MacDonald TM
    Br J Clin Pharmacol; 1999 Nov; 48(5):756-60. PubMed ID: 10594479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and diagnosis of primary aldosteronism.
    Rayner BL
    Cardiovasc J S Afr; 2002; 13(4):166-70. PubMed ID: 12389057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
    Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
    J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The aldosterone/renin ratio as a screening test for primary aldosteronism.
    Rayner BL; Opie LH; Davidson JS
    S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of the post-captopril test in primary aldosteronism.
    Castro OL; Yu X; Kem DC
    Hypertension; 2002 Apr; 39(4):935-8. PubMed ID: 11967253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension.
    Lonati C; Bassani N; Gritti A; Biganzoli E; Morganti A
    J Hypertens; 2014 Mar; 32(3):627-34. PubMed ID: 24445391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient screening tests for primary aldosteronism.
    Dunn PJ; Espiner EA
    Aust N Z J Med; 1976 Apr; 6(2):131-5. PubMed ID: 1067811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
    Mulatero P; Rabbia F; Milan A; Paglieri C; Morello F; Chiandussi L; Veglio F
    Hypertension; 2002 Dec; 40(6):897-902. PubMed ID: 12468576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.